The
global Hybrid Imaging Market size
is expected to reach USD 9.8 billionby 2026, according to a new report by Grand
View Research, Inc., registering a 4.5% CAGR over the forecast period.
Increasing demand for accurate diagnostic techniques for cancer and cardiac
disorders is expected to drive the market. Rising government initiatives for
creating awareness regarding multimodal imaging devices are also expected to
contribute toward market growth.
Increasing
installation of such devices in research centers and institutions to enhance
diagnostics in the field of oncology, cardiology, neurology, and others is
expected to boost market growth. Leading players in the market are showcasing
various multimodal imaging devices at medical conferences to increase their
product reach. However, high cost and complications associated with these
devices is expected to impede market growth during the forecast period.
Hybrid
imaging devices require skilled professionals to understand the data collected
by these combined devices. Therefore, various training programmes are conducted
by several non-profit and government funded organizations to increase the
adoption of hybrid imaging devices for the diagnosis of a disease.
North
America dominated the hybrid/multimodal imaging market in 2018 and is expected
to grow at a significant rate during the forecast period. The growth observed
in this region is largely due to presence of global players and increasing
adoption of advanced equipment such as hybrid imaging devices. Moreover,
increasing awareness regarding nuclear medicine and molecular diagnostics in
the region is expected to contribute toward the growth in this region.
Asia
Pacific is expected register the strongest growth over the forecast period.
This can be primarily attributed to growing usage of advanced devices such as
PET/CT systems in radiology departments across emerging economies. Thriving
medical tourism in numerous countries has piqued the interest of global market
players, who are looking to invest in the development and launch of advanced
software in the region. The Europe market is fueled by ongoing efforts by
various non-profit organizations in conducting educational and training
programs for scientists, physicians, technologists, physicists, radiographers,
and others in the field.
Browse
Details of Report @
https://www.grandviewresearch.com/industry-analysis/hybrid-imaging-market
https://www.grandviewresearch.com/industry-analysis/hybrid-imaging-market
Further key findings from the report suggest:
- PET/CT
systems held the largest share in 2018 based on type, and the segment is
expected to grow at a significant pace due to increasing development and
installation of these devices in various end users such as hospitals and
diagnostic centers
- SPET/CT
systems segment in hybrid imaging market will exhibit the fastest growth
rate during the forecast period. Data captured by SPET/CT helps in
understanding the detailed morphology and pathogenesis of a disease,
thereby enhancing the quality of diagnostic output
- In 2018, the
oncology segment held the dominant share of hybrid imaging systems market
by application, largely due to increasing number of cancer cases and
growing awareness for cancer diagnosis
- The
cardiology segment is expected to grow at the fastest pace during the
forecast period. Cardiac hybrid imaging helps in accurately capturing
morphological and functional information in a single setting, thereby
easing the diagnosis of cardiac disorders
- Hospitals
held the largest market share in 2018 on the basis of end use, mainly due
to higher installation of technologically advanced devices for early
diagnosis and treatment of a disease
- Geographically,
Asia Pacific is expected to register the fastest growth rate during the
forecast period due to increasing number of radiology departments in the
region and launch of advanced software by leading players.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment